Who to call at Hemab Therapeutics Holdings, Inc., and when
Fundz watches for the moments Hemab Therapeutics Holdings, Inc. starts buying, and tells you who to reach.
- An alert the day Hemab Therapeutics Holdings, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Hemab Therapeutics Holdings, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Hemab Therapeutics Holdings, Inc.. With Fundz connected, it knows.
Hemab Therapeutics Holdings, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
hemab.comAI Executive Summary
AI-powered analysis of 8-K filing content
Keli Walbert was elected as a Class I director of Hemab Therapeutics Holdings, Inc. on September 24, 2026, and appointed to the Audit Committee, reflecting the company's effort to strengthen its governance structure and board oversight capabilities.
Key Takeaways
Keli Walbert joins the Board of Directors as a Class I director with a term expiring at the 2027 annual stockholder meeting
Ms. Walbert has been appointed to the Audit Committee, indicating the company is prioritizing financial oversight and governance
2 more takeaways
Filing Overview
What This Means
Hemab Therapeutics Holdings, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.